NECTAR LIFESCIENCES
Back to Balance Sheet
|
NECTAR LIFESCIENCES Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹1,022 Cr | ₹973 Cr | ₹891 Cr | ₹1,004 Cr | ₹1,187 Cr |
What is the latest Total Current Liabilities ratio of NECTAR LIFESCIENCES ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹1,022 Cr |
| Mar2024 | ₹973 Cr |
| Mar2023 | ₹891 Cr |
| Mar2022 | ₹1,004 Cr |
| Mar2021 | ₹1,187 Cr |
How is Total Current Liabilities of NECTAR LIFESCIENCES Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,022 Cr | 5.01 | |
| Mar2024 | ₹973 Cr | 9.19 | |
| Mar2023 | ₹891 Cr | -11.25 | |
| Mar2022 | ₹1,004 Cr | -15.46 | |
| Mar2021 | ₹1,187 Cr | - | |
Compare Total Current Liabilities of peers of NECTAR LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NECTAR LIFESCIENCES | ₹281.5 Cr | -16.4% | -31.3% | -59.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹401,541.0 Cr | -3.6% | -6.8% | -5.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,031.0 Cr | -5.4% | -2.4% | 3.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹138,451.0 Cr | 3.6% | 8.5% | 23.5% | Stock Analytics | |
| CIPLA | ₹112,377.0 Cr | -5.1% | -7.1% | -3.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,355.5 Cr | -4.1% | -8.3% | -12.1% | Stock Analytics | |
NECTAR LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NECTAR LIFESCIENCES | -16.4% |
-31.3% |
-59.6% |
| SENSEX | -0.4% |
-1.7% |
9.1% |
You may also like the below Video Courses